Chugoku Rosai Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Primary biliary cholangitis1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• CG Oncology, Inc.1 trial
• Ipsen1 trial

Running trials

• Active, not recruiting

  A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

  NCT06730061· Phase 3· Ipsen· Source

• Active, not recruiting

  Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

  NCT04452591· Phase 3· CG Oncology, Inc.· Source